GE Healthcare Announces Licensing Agreements with Bristol-Myers Squibb and Regeneron Pharmaceuticals for Green Fluorescent Prote
Access to GFP technology aids drug discovery and development
11-Jun-2004 -
Chalfont St. Giles, UK: GE Healthcare, a combination of
the former Amersham and GE Medical Systems, today announced that
Bristol-Myers Squibb and Regeneron Pharmaceuticals have each signed
licensing agreements for rights to Aequorea Victoria Green Fluorescent
Protein (AvGFP), the most versatile, ...
Amersham
biotechnology
Bristol-Myers Squibb
+8